Jean-Luc Prétet

Professor

Centre Hospitalier Universitaire Vaudois

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jean-Luc Prétet is a Professor at the Centre Hospitalier Universitaire de Besançon in France. His research primarily focuses on the epidemiology and molecular biology of human papillomavirus (HPV), with recent publications addressing HPV infection patterns and genotype distribution among cervical lesions. His work also evaluates diagnostic methods for high-risk HPV detection and its clinical implications.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Nicolas Fazilleau

FRANCE

View details

maxime battistella

Assistant professor

Université Paris Diderot

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Luc Prétet

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

High-Risk Human Papillomavirus Positive-Negative-Positive Infection Pattern Revealed Infection Below the Screening Test Cutoff

Human papillomavirus genotype distribution among high-grade cervical lesions in French women born between 1972 and 1993

The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high‐risk HPV

The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions

The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions

Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR‐HPV assay (Abbott)

Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott)

Anogenital distribution of mucosal HPV in males and females before and after renal transplantation

Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen)

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening

Human papilloma virus‐16‐specific CD8+ T‐cell expansions characterize different clinical forms of lichen planus and not lichen sclerosus et atrophicus

High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study

High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study

Human cytomegalovirus-viruria in hematopoietic stem cell transplant recipients: Context and impact

New recommendations for cervical cancer screening in France,Nouvelles recommandations pour le dépistage du cancer du col de l'utérus en France

HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar

HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar

Longitudinal follow-up of HPV16 sequence after cervical infection: Low intrahost variation and no correlation with clinical evolution

Longitudinal follow-up of HPV16 sequence after cervical infection: Low intrahost variation and no correlation with clinical evolution

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry

Collaborators (2)

Nicolas Fazilleau

maxime battistella

Make your next move.